Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-62.28	136.84	362.77
Graham Fair Price	238.47	5.11	1.51
PEG	-99.29	< 0.005	0.52
Price/Book	2.97	0.79	0.77
Price/Cash Flow	13.56	18.50	-16.29
Prices/Earnings	91.82	-4.12	-50.38
Price/Sales	-91.68	1.76	21.21
Price/FCF	13.56	18.50	-16.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-78.52	0.06	0.29
Operating Margin	-23.40	-0.13	-0.11
ROA	-1269.78	-0.01	< 0.005
ROE	< 0.005	-0.05	-1158.72
ROIC	< 0.005	-0.03	-1317.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.08	< 0.005	895.47
Dividends QOQ	0.89	0.67	-25.33
EBIT QOQ	0.95	-13.57	1330.42
EPS QOQ	0.97	-11.18	1055.59
FCF QOQ	-4.32	1.87	-56.82
Revenue QOQ	-0.87	10.81	1138.75
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	8614.60	464.65	-94.61
Days Sales Outstanding (DSO)	64.73	6.60	-89.81
Inventory Turnover	0.01	0.19	1754.02
Debt/Capitalization	0.54	0.53	-1.67
Quick Ratio	0.30	0.41	36.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	5.14	5.20	1.18
Cash	2.61	2.25	-13.76
Capex	< 0.005	< 0.005	-99.81
Free Cash Flow	-0.24	0.21	-13.49
Revenue	0.19	2.21	1080.75
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.75	1.89	7.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	170.80	64.04	-62.51
Naive Interpretation	Member

06 - Financial Health · Weak

Rating